Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The master cytokine TGF-β mediates tissue fibrosis associated with inflammation and tissue injury. TGF-β induces fibroblast activation and differentiation into myofibroblasts that secrete extracellular matrix proteins. Canonical TGF-β signaling mobilizes Smad2 and Smad3 transcription factors that control fibrosis by promoting gene expression. However, the importance of TGF-β-Smad2/3 signaling in fibroblast-mediated cardiac fibrosis has not been directly evaluated in vivo. Here, we examined pressure overload-induced cardiac fibrosis in fibroblast- and myofibroblast-specific inducible Cre-expressing mouse lines with selective deletion of the TGF-β receptors Tgfbr1/2, Smad2, or Smad3. Fibroblast-specific deletion of Tgfbr1/2 or Smad3, but not Smad2, markedly reduced the pressure overload-induced fibrotic response as well as fibrosis mediated by a heart-specific, latency-resistant TGF-β mutant transgene. Interestingly, cardiac fibroblast-specific deletion of Tgfbr1/2, but not Smad2/3, attenuated the cardiac hypertrophic response to pressure overload stimulation. Mechanistically, loss of Smad2/3 from tissue-resident fibroblasts attenuated injury-induced cellular expansion within the heart and the expression of fibrosis-mediating genes. Deletion of Smad2/3 or Tgfbr1/2 from cardiac fibroblasts similarly inhibited the gene program for fibrosis and extracellular matrix remodeling, although deletion of Tgfbr1/2 uniquely altered expression of an array of regulatory genes involved in cardiomyocyte homeostasis and disease compensation. These findings implicate TGF-β-Smad2/3 signaling in activated tissue-resident cardiac fibroblasts as principal mediators of the fibrotic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, cultured human primary cardiac and dermal fibroblasts and immortalized cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ (refs. 19,39,40), IL-1β (ref. 41)) conditions.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“TGF-β1 activates SMAD2/3 signaling, driving pro-fibrotic gene expression and extracellular matrix deposition in cardiac fibroblasts [85].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [85]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, primary human cardiac fibroblasts, primary human dermal fibroblasts, and immortalized human cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ 20,33,34 , IL-1 β 35 ) conditions.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“While numerous studies have implicated a role for TGFβ signaling in maladaptive cardiac remodeling and scar formation in HF 20,33”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · cited 1×
“Heart failure is an increasingly prevalent disease characterized by reduced cardiac output resulting from a progressive loss of cardiomyocytes, ventricular chamber remodeling, and accumulation of interstitial fibrosis (1).”
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528 · cited 1×
“Global TGF-β activity is upregulated in diseased hearts, where one of its primary actions is directed at the resident fibroblasts to alter the fibrotic response and ventricular remodeling (47, 48).”
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew082 · Cited by 2,425 · cited 1×
“The ratio of these measures ( E/e ′ ) was used as an indicator of diastolic function (60).”
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984 · cited 1×
“Progressive cardiac fibrosis in heart failure is predominantly mediated by the tissue-resident cardiac fibroblast, which becomes activated and then differentiated into a cell type referred to as the myofibroblast (5, 6).”
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934 · cited 1×
“TGF-β is considered a “master” cytokine/growth factor produced within injured or diseased tissues, where it activates fibroblasts and facilitates ECM production (15, 16).”
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 6×
“Hence, here we used mice in which the Postn genetic locus was targeted with a tamoxifen-inducible MerCreMer (MCM) cDNA (29), and these mice were crossed with Smad2 fl/fl , Smad3 fl/fl , Smad2/3 fl/fl , and Tgfbr1/2 fl/fl targeted mice (Figure 2A).”
InfluentialSelf-citation
Cited by
Items 701–800 of 925
Matrifibrocytes Redefine Cardiac Fibrosis: From Terminal Differentiation to Translational Modulation
Zhang, Z., & Zhu, H. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71174 · Cited by 4
“Key transcriptional drivers include SRF [29], MRTF-A [30–32], Smad3 and YAP/TAZ (herein TAZ refers to the transcriptional coactivator with PDZ-binding motif encoded by WWTR1 per HGNC (HUGO Gene Nomenclature Committee) nomenclature, distinct from Tafazzin which shares the TAZ abbreviation) [33, 34].”
Cardiac remodeling in chronic heart failure: pathophysiological implications
Shah, A. K., & Dhalla, N. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822972-9.00015-8 · Cited by 3
Quan, B., Liu, X., Li, Z.-Y., Han, S., Cui, Q., Chang, S.-Y., Lv, S., Yin, X., & Liang, S. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111673 · Cited by 3
piRNA, the hidden player in cardiac fibrosis: A review
Li, Y., Fang, B., He, Y., Wang, Y., Wang, K., & Yang, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146437 · Cited by 3
Cell Cycle Perturbation Induces Collagen Production in Fibroblasts
Wake, M., Takeda, N., Isagawa, T., Sato, T., Nakagama, Y., Morioka, M. S., Hirota, Y., Asagiri, M., Maemura, K., Manabe, I., et al. (2019) · International Heart Journal · doi:10.1536/ihj.18-710 · Cited by 3
Cell Cycle Arrest-Driven Fibrosis
Oshima, T., & Fujiu, K. (2019) · International Heart Journal · doi:10.1536/ihj.19-293 · Cited by 3
Chen, K., Guan, Y., Ma, Y., Quan, D., Zhang, J., Liu, X., Wu, S., Lv, L., & Zhang, G. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113922 · Cited by 3
Shoemaker, R., Meinhardt, J., Heyman, A., & Lark, D. (2021) · Medical Research Archives · doi:10.18103/mra.v9i10.2585 · Cited by 2
Guo, Y., Li, R., & Dang, X. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2285 · Cited by 3
Liu, B., Chen, M., & Meng, W. (2022) · BioMed Research International · doi:10.1155/2022/2055738 · Cited by 3
“Among them, mediators related to cardiac fibrosis include transforming growth factor-β (TGF-β) and platelet-derived growth factor [7].”
BackgroundRetractedZhang, Y., Chen, Y., Wu, B., Liu, D., Fu, L., & Huang, F. (2022) · Nanoscale · doi:10.1039/d2nr01954j · Cited by 3
Mukai-Sasaki, Y., Liao, Z. X., Yang, D. J., & Inoue, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.984364 · Cited by 3
Distribution and chemotactic mechanism of CD4+ T cells in traumatic tracheal stenosis
Feng, T., Chen, Y., Wei, J., Tan, S., & Guangnan, L. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.916 · Cited by 3
Kim, T. Y., Kim, A., Aryal, Y. P., Sung, S., Pokharel, E., Neupane, S., Choi, S., Ha, J., Jung, J., Yamamoto, H., et al. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31148 · Cited by 3
“Fibroblasts and osteoblasts react differently to TGF ‐ β 1 ‐ SMAD2/3 signaling during their differentiation into connective tissue versus bone, respectively (Fujii et al., 2010; Khalil et al., 2017).”
BackgroundWu, X., Meng, Y., Chen, J., Zhang, Y., & Xu, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122578 · Cited by 3
TGFβ1 Regulates Cellular Composition of In Vitro Cardiac Perivascular Niche Based on Cardiospheres
Goltseva, Y., Дергилев, К. В., Boldyreva, M. A., Parfyonova, Y. V., & Beloglazova, I. B. (2024) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-024-06142-8 · Cited by 3
Biomarcadores Potenciais na Fibrose Miocárdica: Uma Análise Bioinformática
Cheng-Mei, W., Luo, G., Liu, P., Ren, W., & Yang, S. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230674 · Cited by 3
Castro, C., Patin, J., Jajkiewicz, C., Chizelle, F., Cerpa, C. O., Tessier, A., Pogam, E. L., Fellah, I., Baró, I., Charpentier, F., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07636-5 · Cited by 3
Wu, J., Liu, X., Wang, M., Wang, X., Luo, D., & Su, S. (2020) · International Heart Journal · doi:10.1536/ihj.19-321 · Cited by 3
Fridman, N. V., Linkova, N. S., Kozhevnikova, E. O., Gutop, E. O., & Khavinson, V. K. (2020) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-020-05022-1 · Cited by 3
Molecular Pathways and Animal Models of Cardiomyopathies
Orgil, B., & Purevjav, E. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_64 · Cited by 3
Thottakara, T., Padmanabhan, A., Tanriverdi, T., Thambidurai, T., Diaz-Rg, J. A., Amonkar, S., Olgin, J. E., Long, C. S., & Abraham, M. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.24.589078 · Cited by 3
A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease
Ariyaratne, G. H. D. N., Villatore, A., Peretto, G., & Chelko, S. P. (2026) · Cells · doi:10.3390/cells15100868 · Cited by 2
“TGF-β 1 activates SMAD2/3 signaling, driving pro-fibrotic gene expression and extracellular matrix deposition in cardiac fibroblasts [85].”
Dauz, J. D., Yazaki, K., Akazawa, Y., Meister, T. A., Kabir, G., Kadowaki, S., Honjo, O., Heximer, S. P., Wald, R. M., Connelly, K. A., et al. (2025) · Physiological Reports · doi:10.14814/phy2.70339 · Cited by 2
“Our current findings align with the known role of activated SMAD2/3 in driving myofibroblast transition, increasing expression of α - SMA and POSTN, and cardiac fibrosis, including increased collagen I expression (Khalil et al., 2017).”
Wang, C., Jiang, X., Han, S., Zang, H., & Gao, X. (2025) · Journal of Natural Medicines · doi:10.1007/s11418-025-01911-9 · Cited by 2
“Furthermore, TGF-β1 exerts its effects on fibroblasts by inducing phenotypic transformation through secretion [35].”
Dynamic chromatin accessibility landscape changes in cardiac fibrosis
Liu, Z., Liu, P., Lin, L.-C., Yang, J., & Tao, H. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104429 · Cited by 3
Hou, T., Zhang, L., Zhao, L., Gao, F., & Xing, T. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105576 · Cited by 2
“Khalil et al. (2017) identified TGF-β -Smad2/3 signaling as a pivotal mediator of fibroblast differentiation, with selective blockade of Smad2/3 signaling reducing fibrotic progression.”
Wang, J., & Xu, A. (2025) · Pharmaceuticals · doi:10.3390/ph18101487 · Cited by 3
“TGF-β 1 signaling through SMAD2/3 phosphorylation then drives fibroblast-to-myofibroblast transdifferentiation and excessive collagen deposition, constituting the core fibrotic cascade [45,83].”
Cannabidiol Protects the Neonatal Mouse Heart from Hyperoxia-Induced Injury
Hellberg, T., Schmitz, T., Bührer, C., & Endesfelder, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010146 · Cited by 2
“Hyperoxia strongly induced TGF β signaling in cardiac fibroblasts via oxygen-sensitive pathways, promoting myofibroblast differentiation and extracellular matrix deposition through Smad2/3 signaling [74–76].”
Mapuskar, K. A., Pulliam, C. F., Tomanek‐Chalkley, A., Dierdorff, J. M., Current, K., Beardsley, R. A., London, B., & Allen, B. G. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.042101 · Cited by 2
“6,7 Resident cardiac fibroblasts predominantly drive the progression of cardiac fibrosis mediated by inflammatory cytokines/growth factors, including TGFB (transforming growth factor-beta).”
Wu, J., Zhao, C., Li, X., Guo, X., Tan, W., Zhou, L., Zhang, Y., Zhang, J., Zheng, S., Zeng, C., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70248 · Cited by 3
“In NRCFs, AMF dose-dependently blocks TGF- β1-driven fibrotic responses, including myofibroblast transdifferentiation and ECM deposition (Khalil et al. 2017).”
Bertossi, D., Cavallini, M., Camporese, A., Dell’Avanzato, R., Kefalas, N., Massidda, E., Papagni, M. F., Patalano, M., Quartucci, S., Renga, M., et al. (2026) · Facial Plastic Surgery · doi:10.1055/a-2764-3062 · Cited by 3
Yan, D., ji, T., Liang, X., Luo, M., Huang, Y., Luo, P., Yang, Z., Zhang, L., Li, T., Bai, Y. P., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202501262rr · Cited by 2
Li, Y., Chai, H., Ko, S., Chang, C., Chu, C., Cheng, B., Yip, H., & Yang, C. (2026) · The FASEB Journal · doi:10.1096/fj.202503723r · Cited by 2
“TGF-β and its downstream effector p-Smad3 are key mediators in the pathogenesis of cardiac or renal fibrosis, promoting the differentiation of fibroblasts into myofibroblasts and the production of extracellular matrix proteins [43–46].”
Chen, C., Lu, W., Pan, Q., Chuanjue, C., Zhang, Y. N., Wang, H., Han, J., Sheng, Y., Lin, Z., Xie, Y., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04431-0 · Cited by 2
“Significant attenuation of fibroblast activation and fibrosis was observed after the inhibition of TGF-β1/Smad3 signal by traditional Chinese medicine [41], fibroblast-specific deletion [42], non-coding RNA [43, 44], and small molecular inhibitors such as SIS3 [9, 45].”
Wu, Z., Zou, X., Chen, C., Zhou, M., Yue, X., Guo, D., Gao, Y., Ma, C., Han, Q., Yang, D., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.04.003 · Cited by 4
Zhu, Y., Ran, Y., Fu, T., Zheng, X. M., Chen, Y., Liang, C., Li, Y., Huang, R., Zhao, H., Pan, X., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1786720 · Cited by 2
“The TGF-β pathway is a well-established pathway that activates cardiac fibrosis and is involved in all types of fibrosis (Frangogiannis, 2022; Meng et al., 2016; Khalil et al., 2017; Dobaczewski et al., 2011).”
Let-7a-5p targets MAP3K1 to regulate the MAPK signaling pathway in a depression model
Fei, S., Li, Q., Xiang, J., Wang, H., & Shang, X. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106182 · Cited by 2
The cardiac 4D nucleome: nuclear and chromatin dynamics across development, disease and ageing
Wang, Y., & Dobreva, G. D. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01322-7 · Cited by 2
The regulatory logic linking inflammation and fibrosis
Alexanian, M., & Srivastava, D. (2026) · Cell · doi:10.1016/j.cell.2026.08.001 · Cited by 3
Jiang, H., Malayath, G., Devi, N. D., Chou, H.-Y. C., Kooh, Y. K. G., Guo, J., Ramahdita, G., Nguyen, J., Bhakta, R., Aryan, L., et al. (2026) · APL Bioengineering · doi:10.1063/5.0336866 · Cited by 3
Xu, Y., Zhou, J., Lv, G., Liu, Y., Zhao, X., Li, X., Ye, D.-D., Qu, X., & Huang, X. (2020) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20200218020203 · Cited by 2
Lin, H. R., Xu, W., Liu, X., Wang, Z., Yan, J., & Zhang, T. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10342 · Cited by 2
“Previous studies have revealed that TGF‐β can manipulate myocardial fibrosis by regulating the expression of Smad2/Smad3 and Wnt/β‐catenin pathway‐asso‐ ciated proteins (36,37).”
BackgroundAldehyde Dehydrogenase Isoform 1 Predicts a Poor Prognosis of Acute Cerebral Infarction
Yang, J., Duan, J., Li, M., Sun, H., Sun, Y., Pan, W. D., & Xi, H. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/8199917 · Cited by 2
“*e Smad family directly participates in signal transduction of the transforming growth factor-beta (TGF-β) superfamily, which is critically important in regulating intracellular homeostasis and cell functions [21, 22].”
BackgroundChen, L., Li, M., Shen, M., Zhu, Y., Chen, K., Huang, X., Zheng, C., Wang, Q., Lin, H., Liao, W., et al. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023071 · Cited by 2
“…the results of our KEGG analysis are consistent with previous reports, indicating that the PI3K-Akt signaling pathway [34], TGF-β signaling pathway [35–37], and ECM-receptor interactions and cytokine-cytokine receptor interactions may play important roles in the pathological process of pressure…”
Jiao, Y., Li, X., Liu, X., Li, C., Xiao, Y., Sun, X., Wang, F., & Wang, L. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300997 · Cited by 2
Peng, N., & Xie, J. (2023) · PubMed Central · doi:10.7507/1001-5515.202208039 · Cited by 2
Zhang, Z., Ma, C., Gao, X., Wang, C., Li, Y., Yang, C., Ma, E., & Cheng, M. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108033 · Cited by 2
The role of exercise in bolstering cardiac resilience during aging
Saini, A. S., Foote, K., Bennett, M. R., & Vujić, A. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.18 · Cited by 2
Nagy, L., Nagy, G., Juhász, T., Fillér, C., Szűcs, G., Szekanecz, Z., Vereb, G., Antal‐Szalmás, P., & Szöőr, Á. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062618 · Cited by 2
“Future studies should explore the molecular drivers of cardiac fibrosis in these models, including the role of transforming growth factor β (TGF-β ) signaling and fibroblast-specific gene expression [24].”
Shu, C., Ren, C., Chen, Q., Wang, Y., Li, R., Zhang, Y., Yang, S., Wang, C., & Li, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1627255 · Cited by 3
Liu, Y., Shen, P., Li, G., Wang, T., Gao, C., Sun, Y., Zhou, Y., Luo, L., Li, J., Wang, X., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf239 · Cited by 2
Qian, J., Jackson‐Weaver, O., Shen, Y., Jin, J. J., Chen, Y., Li, M., Subramanyan, R. K., & Xu, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.24.595777 · Cited by 2
“We stimulated hCF with TGF b , a potent inducer of fibroblast activation that leads to fate transition into myofibroblasts 4, 9, 10 .”
MethodKervella, M., Peccate, C., Guesmia, Z., Grandi, F. C., Mougenot, N., Forand, A., Charrabi, A., Brochier, G., Andriantsitohaina, R., Méli, A. C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.10.632312 · Cited by 2
Targeting RUNX1 in Macrophages Facilitates Cardiac RecoveryPreprint
Amrute, J., Zhu, A., Pai, Y.-L., Hector-Greene, M., An, Y., Kim, K. R., Sheth, M. U., Padmanabhan, A., Lee, C. Y., Yamawaki, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.25.665779 · Cited by 8
Кольберг, Н. А., Тихонов, С. Л., Тихонова, Н. В., Moskovenko, N. V., Мифтахутдинов, А. В., & Prosekov, A. Y. (2021) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2021.102214 · Cited by 1
Assi, L. A., Alkhansa, S., Njeim, R., Ismail, J., Madi, M., Ghadieh, H. E., Almoussawi, S., Azar, T. S., Ayoub, M., Azar, W. S., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070955 · Cited by 2
“Activated transforming growth factor beta (TGF-β ) leads to cardiac fibrosis and mediates endothelial-to-mesenchymal transition which in turn induces DCM through the SMAD-dependent and independent pathways [6].”
BackgroundMethodInfluentialWang, H., Niu, P., Li, H., Feng, L., Li, Z., Bai, M., & Peng, L. (2025) · Plant Foods for Human Nutrition · doi:10.1007/s11130-025-01343-6 · Cited by 1
Discovery of novel anti-fibrotics through phenotypic screening
Lapthorn, A. R., Harding, S. L., Feltham, K. M., Ilg, M. M., & Cellek, S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104450 · Cited by 1
Tak, K. A. (2025) · American Journal of Cardiovascular Disease · doi:10.62347/hmvt2954 · Cited by 1
Chu, Y., Zhu, J., Chen, S., Lin, X., Zhou, Z., Shen, R., Wang, H.-S., Chen, L., Lin, J., Zhang, H., et al. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.10.006 · Cited by 1
Targeting SYK with miR-512-3p provides therapeutic potential in myocardial fibrosis
Li, W., Yang, W., Hou, F., Li, Y., Yang, Y., Narigele, Nie, Y., Zhi, L., Liu, J., Lu, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-21415-6 · Cited by 1
Wan, L., Li, H., Fong, H., Su, X., Wen, J., Shao, X., Yan, Z., & Wang, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00357-5 · Cited by 1
“The TGF-β-mediated TGF-BR1-Smad2/3 signaling pathway activation plays an integral role in cardiac fibrosis [34].”
Watcharanapapan, W., Hirunsai, M., & Srikuea, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-25496-1 · Cited by 1
“Although TGF-β1/Smad2/3 signalling has been reported as the canonical pathway inducing fibrosis development 50,51 , the pathway mediating the effects of TGF-β1 and D 3 /its metabolites in skeletal muscle cells could be potentially through non-canonical pathways, i.e., p38 mitogen-activated protein…”
Li, X., Dai, Z., Ren, X., Zhao, H., Chan, L., Wu, R., Xiao, X., Liu, Q., & Su, L. (2025) · Journal of Environmental Sciences · doi:10.1016/j.jes.2025.09.017 · Cited by 2
Zhang, Y., Li, N., Chu, S., Fu, H., Yang, X., Xia, H., Xiao, Y., Xiao, Z., Liu, J., Dong, Y., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1723889 · Cited by 1
Liu, S., Wu, X., Xue, Y., Qi, M., Li, T., Zhang, Y., & Fang, M. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124221 · Cited by 1
Activation of Cannabinoid Receptor 1 Enhances Wound Healing by Promoting the Proliferative Phase
Cui, H. S., Zheng, Y. X., Cho, Y. S., Jung, Y. G., Kwak, I. S., Ro, Y. M., Joo, S. Y., Kim, J.-B., & Seo, C. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031171 · Cited by 1
“In the present study, we mechanistically show that CB1 activation induces phosphorylation of SMAD2 and SMAD3, indicating a potential interaction with canonical TGF-β signaling, which is known to regulate fibroblast activation and fibrogenesis [23,24].”
Jin, Q., Chen, C., Wu, P., Li, L., Jiang, L., Chen, R., Xu, S., Huang, Y., Xu, H., & Long, X. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10159-2 · Cited by 1
Yoshida, H., Teranishi, H., Shikano, K., Kato, H., Apolinario, M. E. C., Hanada, T., Hikida, T., & Hanada, R. (2026) · Peptides · doi:10.1016/j.peptides.2026.171474 · Cited by 1
Liu, S., Ding, M., & Zhang, Y. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124292 · Cited by 1
Genome folding and nuclear speckles converge to orchestrate fibroblast activation
Gardner, Z., Linares-Saldana, R., Haridhasapavalan, K. K., Fernández, P. O. M., Barka, V., Yang, R., Koch-Bojalad, B. A., Padmanabhan, A., Wang, Q., Shah, P. P., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec3453 · Cited by 1
Aslan, F., Binici, S., Eryılmaz, İ., Beğer, B., Beğer, O., İliklerden, Ü. H., ÖZALP, İ., İlik, Z. A., Karakoyun, F., Şahinalp, Ş., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14030698 · Cited by 1
Zhu, C., Xue, Y., Hong, W., Zhu, Y., Miao, X., Guo, Y., Xu, Y., Fang, M., & Kong, M. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag066 · Cited by 1
Jaiswal, S., Sharma, G., & Barthwal, M. K. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70405 · Cited by 1
“Fibrosis is known to be associated with increased TGF-β expression and its effect on collagen expression (Khalil et al., 2017).”
Blagojevic, N., Blagojevic, D., Matovic, A., Cvrkotic, M., Marjanovic-Haljilji, M., Šljivić, A., Ilić, A., Cvetinovic, N., Nenadic, I. N., Djuric, M. D., et al. (2026) · Antioxidants · doi:10.3390/antiox15040490 · Cited by 1
“In parallel, capillary rar-efaction and impaired matrix turnover establish a self-perpetuating loop in which fibrosis feeds back to maintain oxidative stress and structural disarray [77–79].”
From Adipose Tissue to Cardiac Repair: Extracellular Vesicles in Cardiovascular Regeneration
Ignaczak, K., Ochocka, P., Sadowski, K., Ploch, W., Tomkiel, D., Tomaniak, M., & Olejarz, W. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71148 · Cited by 1
“This pathway is implicated in the activation of cardiac fibroblasts, which may contribute to cardiac fibrosis after MI [19].”
Roles of gut and oral microbiota in methamphetamine-induced multi-organ toxicity
Rong, J., Zhuang, J., Xu, J., Yue, X., & Chen, X. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10182-3 · Cited by 1
“…the development of non-ischemic heart failure by triggering myocardial hypertrophy and fibrosis via the TGF-β/Smad signaling pathway, while also compromising mitochondrial energy production, altering DNA methylation patterns, and disrupting intracellular calcium transport (Khalil et al. 2017).”
CK2α Deficiency Drives Myocardial Fibrosis via Desmin‐Induced Mitochondrial Dysfunction
马灿杰, Jia, J., Lan, J., Wang, J., Rao, D., Rao, L., Zhang, W., Wu, D., Zhang, J., Wang, G., et al. (2026) · Advanced Science · doi:10.1002/advs.75560 · Cited by 1
“Concurrently, TGF-β 1 functions as a master regulator of fibrotic gene programs, with extensive studies demonstrating that it activates cardiac fibroblasts primarily through SMAD-dependent signaling pathways, particularly via Smad2/3 phosphorylation [ 48 ].”
Conserved Transcriptional Circuits Regulate Cardiac Fibroblast-Mediated Fibrosis
Krstevski, C., Farrugia, G. E., Hsu, I., Dona, M. S. I., Gaynor, T. L., Cohen, C. D., Harper, R. L., Harrison, T. I., Raffaut, S. R., Claridge, B., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327294 · Cited by 1
“14,41 Therefore, selective SMAD signaling may partly explain why Fibro-CT cells do not exhibit characteristics of myofibroblasts—defined by α SMA/ACTA2 expression.”
IRF7 links HK1-dependent histone lactylation to fibroblast activation and cardiac fibrosis
Kong, M., Zhu, C., Xue, Y., Hong, W., Zhang, G., Jiang, D., Xu, Y., & Guo, J. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00444-2 · Cited by 1
Dou, X., Wan, H., Chen, T., Zhou, H., Li, Y. X., & Wan, H. (2026) · Pharmaceuticals · doi:10.3390/ph19050755 · Cited by 1
“In this study, cardiomyocyte-specific overexpression of GATA4 in the MF state reduced the release of the profibrotic factor TGF-β , which may, in turn, attenuate fibroblast activation by suppressing downstream SMAD signaling [36].”
Liu, Y., Sun, X., Sun, W., & Li, R. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117889 · Cited by 1
Huang, Y., Luo, L., Ma, X., Huang, Y., Zhang, C., Hao, X., Zhang, L., Zhu, H., Dai, L., & Liu, M. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047429 · Cited by 1
“71 C- X-C motif chemokine receptor 4 + macrophages contribute to fibroblast- to-myofibroblast transition via CXCL3, 57 whereas TGF-β 1 secretion initiates collagen production 72 and establishes autoregulatory loops that sustain its own expression.”
Huang, H.-J., Yang, Q.-S., Zhou, Z.-F., Sun, C., & Zhu, B.-M. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154452 · Cited by 1
Wang, M., Liu, Z., Chen, Y., Wang, S., Ma, Y., Wang, J., Zheng, K., Li, M., Wu, M., Fan, Z., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag632 · Cited by 1
Chen, X., Bao, Y., & Zhang, Q. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07950-y · Cited by 1
Pan, Y., Li, W.-H., Zhang, W., Ma, W., & Sun, H. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00599-x · Cited by 1
“In hypertrophic and fibrotic remodeling, patient hypertrophic cardiomyopathy (HCM) data and pressure-overload models [14–17], as well as fibroblast extracellular matrix (ECM) programs [18, 19], should be handled as related but non-equivalent evidence streams.”
Bai, F., Yang, G., Eskew, J. R., Wang, N.-P., Bose, H. S., & Zhao, Z. (2020) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2020.114010 · Cited by 1
“In previous in vivo studies, it has been shown that CD44 overexpression plays a critical role in the migration of fibroblasts to sites of injury and differentiation of fibroblasts to myofibroblasts, mainly depending upon Ang II activated TGF-β1 signaling pathway [7] [13] [21].”
BackgroundDYNAMIC BIOREACTOR MODEL TO MIMIC EARLY CARDIAC FIBROSIS IN DIABETES
Marsh, S. R., RAUDAT, M., LEFEBER, B., HERNDON, L. B., Herbert, H., McCallum, L. E., & Simionescu, A. (2021) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519421500470 · Cited by 2
[The potential role of calnexin in the activation of cardiac fibroblasts].
Tian, G., Zhao, M., Zhou, J., Quan, Y., Wu, W., & Liu, X. (2020) · PubMed Central · doi:10.7507/1001-5515.202001052 · Cited by 1
Signaling pathways in cardiac fibrosis; A review and future therapeutic options
Elsayed, M. O. K., Moustafa, Y. M., Mehanna, E. T., El-Sayed, N. M., & Hazem, R. M. (2023) · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences · doi:10.21608/rpbs.2023.238923.1244 · Cited by 1
The role and mechanism of CRISPLD2 in skin fibrosis of systemic sclerosis
Ding, L., Bao, D., Dai, B., Meng, Q., Lv, C., Luo, H., & Zhu, H. (2024) · Rheumatology · doi:10.1093/rheumatology/keae541 · Cited by 1
Bradshaw, A. D. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.01.006 · Cited by 1
[The preparation of Ag/AgCl nanoparticle and its resonance scattering spectroscopic study].
Ling, S. M., Jiang, Z. L., Bi, X. S., & Yi, X. H. (2001) · PubMed · Cited by 1
Cardiac fibroblasts regulate cardiomyocyte hypertrophy through dynamic regulation of type I collagenPreprint
Meng, Q., Bowers, S. L. K., Kuwabara, Y., Huo, J., Minerath, R., York, A. J., Sargent, M. A., Prasad, V., Saviola, A. J., Galindo, D. C., et al. (2022) · bioRxiv · doi:10.1101/2022.05.25.493406
Self-citationAbietane Diterpenes and Benzofuran Neolignans from the Resins of Toxicodendron VernicifluumPreprint
Liu, Q., Chen, X., Wang, S., Li, C., Zhao, M., Tu, P., & Jiang, Y. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4185398 · Cited by 1
Maintaining Matrix Composure Under Stress
Stempien‐Otero, A. (2019) · Circulation Research · doi:10.1161/circresaha.119.314843 · Cited by 1
Physiopathologie des cardiopathies liées à Nav1.5 : rôle des fibroblastes cardiaques
Castro, C. (2019) · theses.fr (ABES) · doi:10.70675/9d82ef5az8e5dz48b5zafaez5c0c6a51333e · Cited by 1
Blythe, N. M. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Metadata
- Authors
- Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., Karch, J., & Molkentin, J. D.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Johns Hopkins University (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-09-11
- Volume
- 127
- Issue
- 10
- Pages
- 3770-3783
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5617658
- OpenAlex
- W2750808153
- Cited by
- 905
- References
- 64
- Citations by year
- 2026: 92 · 2025: 102 · 2024: 128 · 2023: 121 · 2022: 144 · 2021: 110 · 2020: 84 · 2019: 85 · 2018: 34 · 2017: 2
- FWCI
- 43.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Language arts journal of Michigan (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (158486, 148429)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL069779, R01HL105924)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060636)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- myocardial fibrosis, TGF-beta signaling, Smad2, Smad3, cardiac fibroblasts, myofibroblasts, TGF-beta receptor, pressure overload, cardiac hypertrophy, extracellular matrix remodeling
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type I, Receptor, Transforming Growth Factor-beta Type II, Animals, Fibrosis, Heart Diseases, Male, Mice, Transgenic, Myocardium, Organ Specificity, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Myocytes, Cardiac, Mice, Smad2 Protein, Smad3 Protein, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.